BLPH - Bellerophon Therapeutics: A Promising Solution To America's Ventilator Shortage During The COVID-19 Pandemic
The United States has a critical shortage of ventilators as it battles the coronavirus outbreak. One small cap biotech company by the name of Bellerophon Therapeutics, Inc. (BLPH) may have a novel solution to help alleviate the demand for ventilators. The FDA recently granted the company Emergency Expanded Access for INOpulse® for the treatment of COVID-19. BLPH moved quickly to treat one patient who was quite ill, and early results are looking promising. I believe that BLPH makes a very strong investment candidate for those investors who are looking to speculate on stocks that could